The anesthesia drug market is expected to be valued at $7 billion by 2015, according to a Markets and Markets report.
The report studies the U.S. Ketamine market from 2007 to 2015 and anticipates moderate growth from 2011 to 2016. Anesthesia drugs included in the report are propofol, midazolam, diazepam and more.
The U.S. general anesthesia market was worth approximately $2 billion in 2011 and should grow 4 percent. Anesthetic drugs account for 65 percent of the general anesthetic drug market.
More Articles on Anesthesia:
Dr. Robert Brooker of Sheridan Healthcare to Discuss Blood Conservation at ASA Meeting
Dr. Mark Romanoff Nominated as Physician of the Year Finalist
Anesthesiologist Updates for Oct. 1, 2014
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.